Increased interest in alcohol moderation, new medications, and flexibility among 12-step proponents is changing how Americans treat alcohol use disorder.
The company hopes to prove that its treatment is more effective, and safer, than Sarepta Therapeutics’ Elevidys.
In this week's edition of "Adam's Biotech Scorecard," Adam also looks at how biotech fared on Wall Street during the Marty Makary era.
The move was praised by animal rights activists that have pressed the Trump administration to reduce animal testing in medical research.
The company said it still plans to move the medicine, called diranersen, into a pivotal study, based on signs it slowed cognitive decline.
In a competitive field, executives at the company, formerly known as Myeloid Therapeutics, express confidence they will win the ‘foot race.’
There is a role for AI in medicine. But in addiction medicine, ‘empathetic’-seeming AI agents could be very risky.
